Neurology-focused NeuroX will participate in CMS’ GUIDE Program
NeuroX, a neurology-focused online consultation service, and its physician network ATP Partners announced it will participate in the Centers for Medicare and Medicaid Services (CMS) GUIDE Program to enhance care for dementia patients.
NeuroX, American TelePhysician’s brain health division, offers a virtual-care platform that connects individuals with neurologists, psychiatrists and sleep specialists to provide what the company touts as a “complete brain health ecosystem.”
The company works with employers, individuals and facilities, offering online screening and consultations, neurodiagnostics, AI-enabled remote patient monitoring and a speech-based cognitive-assessment test dubbed LANGaware.
CMS’ GUIDE Program, which will officially launch July 1, aims to support individuals living with dementia and their caregivers by providing care coordination and care-management services, respite services, and caregiver education and support. Individuals will also have 24/7 access to a support line.
Additionally, the program will provide guidelines for a standard approach to care with the aim of keeping dementia patients living in their homes.
Through the GUIDE Program, individuals suffering from dementia will have access to NeuroX and ATP’s technology platform, including its diagnostics, treatment and home care services.
“GUIDE is the latest innovative CMS value-based program focused on improving clinical quality while lowering health care expenditures for Medicare,” ATP CFO David Spalding said in a statement.
“As a GUIDE participant, ATP will deploy our scalable, award-winning brain health care management platform to support our proprietary specialist telemedicine network and in conjunction with community-based physician groups focused on senior populations with chronic conditions.”
THE LARGER TREND
CMS announced the GUIDE model in July of last year in response to President Biden’s executive order issued three months earlier to increase access to high-quality care and support caregivers.
According to the CDC, approximately 5.8 million people in the U.S. have Alzheimer’s disease or another form of dementia, and by 2060 that number is expected to jump to 14 million people.
Other organizations focused on providing dementia care are Japanese pharmaceutical company Eisai and Oita University, also in Japan, which built an AI model that uses data from wearable devices to predict Alzheimer’s disease, the most common form of dementia.
St. Louis-based Harmonic Health is another tech-enabled dementia-care platform, as is Fujifilm Corporation, which developed AI technology to predict whether patients with mild cognitive impairment will progress to Alzheimer’s disease within two years.
Post Publications || Join us on Whatsapp || Post Disclaimer
SEND A STORY: Do you have a story for us or need a promotion/advertisement? Submit them via our email admin@edulearnweb or Ghanaeducation.org
TELEGRAM PAGE >>> [JOIN]
DOWNLOAD OUR EDUCATION NEWS APP - MOBILE APP
JOIN OUR EDUCATION NEW GROUPS (WHATSAPP)
Join one of our Whatsapp/Telegram Groups for current Ghana Education Service News Updates:
JOIN ONLY ONE... THANKS
TELEGRAM PAGE >>> [JOIN]
Group 1 >>New Group> [JOIN]
Group 2 >>New Group> [JOIN]
TELEGRAM PAGE >>> [JOIN]
Only websites that give us a URL backlink can repost our content on their sites.
The information contained in this post is for general information purposes only. The information is provided by edulearnweb.com and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the post for any purpose.
||About Us|| Contact Us